GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Inflow
Outflow
Net flow
Funds Holding
2,640
Funds Holding Change
-6
Funds Holding Growth
-0.2%
Value
$477B
Holding in Top 10
496
Top 10 Change
-163
Top 10 Growth
-25%
Value Growth
-11%
New
131
Increased
1,181
Reduced
1,164
Closed
104
Capital Inflow
$21.6B
Capital Outflow
$21.6B
Net Capital Flow
+$4.04M
Capital Flow Change
-$8B
Calls
$8.1B
Puts
$7.8B
Net Calls
+$306M
Put/Call Ratio
0.96